1. Home
  2. NVOS vs HUGE Comparison

NVOS vs HUGE Comparison

Compare NVOS & HUGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVOS
  • HUGE
  • Stock Information
  • Founded
  • NVOS 2000
  • HUGE 1998
  • Country
  • NVOS United States
  • HUGE Canada
  • Employees
  • NVOS N/A
  • HUGE N/A
  • Industry
  • NVOS Assisted Living Services
  • HUGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVOS Health Care
  • HUGE Health Care
  • Exchange
  • NVOS Nasdaq
  • HUGE Nasdaq
  • Market Cap
  • NVOS 9.9M
  • HUGE 7.8M
  • IPO Year
  • NVOS 2017
  • HUGE N/A
  • Fundamental
  • Price
  • NVOS $0.60
  • HUGE $0.15
  • Analyst Decision
  • NVOS
  • HUGE
  • Analyst Count
  • NVOS 0
  • HUGE 0
  • Target Price
  • NVOS N/A
  • HUGE N/A
  • AVG Volume (30 Days)
  • NVOS 970.0K
  • HUGE 2.4M
  • Earning Date
  • NVOS 07-30-2024
  • HUGE 07-22-2024
  • Dividend Yield
  • NVOS N/A
  • HUGE N/A
  • EPS Growth
  • NVOS N/A
  • HUGE N/A
  • EPS
  • NVOS N/A
  • HUGE N/A
  • Revenue
  • NVOS $13,658,040.00
  • HUGE N/A
  • Revenue This Year
  • NVOS N/A
  • HUGE N/A
  • Revenue Next Year
  • NVOS N/A
  • HUGE N/A
  • P/E Ratio
  • NVOS N/A
  • HUGE N/A
  • Revenue Growth
  • NVOS 16.91
  • HUGE N/A
  • 52 Week Low
  • NVOS $0.42
  • HUGE $0.13
  • 52 Week High
  • NVOS $5.38
  • HUGE $1.68
  • Technical
  • Relative Strength Index (RSI)
  • NVOS 43.38
  • HUGE 33.67
  • Support Level
  • NVOS $0.51
  • HUGE $0.14
  • Resistance Level
  • NVOS $0.58
  • HUGE $0.15
  • Average True Range (ATR)
  • NVOS 0.07
  • HUGE 0.02
  • MACD
  • NVOS -0.02
  • HUGE 0.01
  • Stochastic Oscillator
  • NVOS 39.95
  • HUGE 40.56

About NVOS Novo Integrated Sciences Inc.

Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services which generates majority of the revenue, and product sales.

About HUGE FSD Pharma Inc. Class B Subordinate Voting Shares

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Share on Social Networks: